AbbVie
ABBV
#30
Rank
C$435.87 B
Marketcap
$246.66
Share price
0.10%
Change (1 day)
19.52%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$195.41 Billion

According to AbbVie's latest financial reports the company's total liabilities are C$195.41 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$164.88 B-0.01%
2022-12-31C$164.89 B-1.3%
2021-12-31C$167.07 B-4.68%
2020-12-31C$175.28 B37.95%
2019-12-31C$127.06 B37.58%
2018-12-31C$92.35 B11.83%
2017-12-31C$82.58 B-0.01%
2016-12-31C$82.59 B21.26%
2015-12-31C$68.11 B127.77%
2014-12-31C$29.90 B13.72%
2013-12-31C$26.29 B11.85%
2012-12-31C$23.51 B204.59%
2011-12-31C$7.71 B42.18%
2010-12-31C$5.42 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$180.56 B-7.60%๐Ÿ‡บ๐Ÿ‡ธ USA
C$108.79 B-44.33%๐Ÿ‡บ๐Ÿ‡ธ USA
C$87.19 B-55.38%๐Ÿ‡บ๐Ÿ‡ธ USA
C$118.59 B-39.31%๐Ÿ‡บ๐Ÿ‡ธ USA
C$51.40 B-73.69%๐Ÿ‡บ๐Ÿ‡ธ USA
C$17.00 B-91.30%๐Ÿ‡บ๐Ÿ‡ธ USA
C$84.91 B-56.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$91.22 B-53.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$1.16 B-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA